Experimental peptides are being advertised for Long COVID (Joshua)
- Condition
- Long COVID
- At worst
- Not stated
- Ill for
- Not stated
- Published
- Jul 2026
Summary
Joshua began microdosing tirzepatide about six months before the article was written, though no specific dose is given. The article does not describe how long he had been sick or how severe his Long COVID was, but he reported that within hours of his first dose he could breathe more deeply and his focus felt sharper. He has continued taking the medication, now with buy-in from his doctors, with no mention in the article of the benefit fading or of relapse.
Read it in their words
thesicktimes.org — this page sells a treatment, program or service.
What they credit
Credits Supplements, GLP-1 drugs (semaglutide, tirzepatide), Stem cells and peptides.
Similar stories
-
ME/CFS patient substantially improved with spironolactone 100 mg daily
Poster combined spironolactone 25mg/day with LDN, a GLP-1 agonist and NP thyroid and states plainly "My CFS is cured, yes cured...my health is amazing," while noting he still needs cortisol supplementation. Because several drugs were changed together it is…
-
Scripps launches digital clinical trial to test repurposed drug for Long COVID
Credits GLP 1. An unnamed patient was ill 1y with very-severe long COVID and reports a substantial improvement. Poster's daughter, bedridden a year, thriving days after Ozempic.
-
Experimental peptides are being advertised for Long COVID
Anca Vrincianu learned about the peptides MOTS-c and KPV, said to help with energy production and gut health respectively, and ordered them online, though the article does not specify the exact peptides she settled on, doses, or duration of use. Over about a…
-
Recovery Protocol Cheat Sheet
Christy's posted recovery protocol lists an extensive regimen: pre-protocol, three months of Eliquis 5 mg daily and clopidogrel 75 mg daily; from February 2024 a "foundation" of nutritional antivirals including matcha green tea, coconut oil, unpasteurized…